← Clinical Trial Results
Atrial FibrillationPhase 4PreventionNCT01288352

EAST-AFNET 4: Complete Statistical Analysis of Early Rhythm Control in Atrial Fibrillation

An independent statistical review of the randomized EAST-AFNET 4 trial evaluating early standardized rhythm control in patients with atrial fibrillation.

Atrial Fibrillation Network · Completed study · Primary completion date 2020-03-06
Scope of this record

This page provides an independent statistical analysis and educational interpretation of publicly reported results. ClinicalTrials.gov provides the official trial registry record.

1. Trial at a Glance

EAST-AFNET 4 was a randomized, parallel-design phase 4 prevention trial evaluating early standardized rhythm control in atrial fibrillation.

2789
Enrollment
2
Study Arms
2011-07-01
Start Date
8 years
Primary Endpoint Time Frame
FeatureEAST-AFNET 4
NCT IDNCT01288352
TitleEarly Treatment of Atrial Fibrillation for Stroke Prevention Trial
StatusCOMPLETED
Lead sponsorAtrial Fibrillation Network
ConditionsAtrial Fibrillation; Stroke
AllocationRandomized
MaskingNone
Primary purposePrevention

2. Clinical Question

Population

Patients enrolled in a trial of atrial fibrillation and stroke prevention.

Intervention

Early standardized rhythm control.

Comparator

The registry identifies two randomized study arms.

Primary question

Does early standardized rhythm control affect the prespecified cardiovascular outcome composite and hospitalization burden?

3. Trial Design

Design

Randomized, parallel assignment.

Arms

2 arms.

Masking

None.

Purpose

Prevention.

4. Endpoints

EndpointDefinitionTime frame
Primary composite endpointA composite of cardiovascular death, stroke and hospitalization due to worsening of heart failure or due to acute coronary syndrome.8 years
Co-primary outcomeNights spent in hospital per year.8 years

5. Planned Analysis

The ClinicalTrials.gov record identifies the primary endpoints but does not report posted statistical analyses or outcome estimates.

For a time-to-first-event composite endpoint such as cardiovascular death, stroke, and hospitalization outcomes, a typical analysis evaluates time until the first qualifying event using survival-analysis methods such as Kaplan-Meier estimation, hazard ratios, and regression-based comparisons. Hospitalization burden measured as nights spent in hospital per year would typically require a method appropriate for repeated or count-like utilization data.

No formal statistical analyses were posted to ClinicalTrials.gov.

6. Statistical Methodology

Time-to-event analysis

The first primary outcome is defined as time to first occurrence of a composite clinical event. Time-to-event methods account for different follow-up durations and patients who do not experience the event during observation.

Conceptual hazard ratio interpretation
HR < 1 → lower estimated instantaneous event rate in one group relative to another

Composite endpoints

A composite endpoint combines multiple clinically meaningful events into one outcome. Interpretation requires understanding which components contribute most strongly and whether components have similar clinical importance.

Hospitalization outcomes

Nights spent in hospital per year represents a different statistical structure from a single first-event endpoint because patients may contribute repeated hospitalization experiences.

7. Statistical Methods Explained

Why use a composite endpoint?

A composite can increase statistical efficiency by counting several types of events, but the individual components remain important for interpretation.

What does a hazard ratio measure?

A hazard ratio compares estimated instantaneous event rates over time. It does not directly represent the percentage of patients experiencing an event.

Why is follow-up time important?

Time frames define the observation window over which endpoint events are assessed.

Why analyze hospital nights separately?

Hospitalization burden captures healthcare utilization and may require methods different from first-event survival analysis.

8. Limitations

9. Why This Trial Matters Statistically

ConceptHow it appears in EAST-AFNET 4
RandomizationRandomized comparison of two study arms.
Parallel designParticipants were assigned in parallel groups.
Composite endpointsPrimary cardiovascular outcome combines multiple events.
Time-to-event analysisPrimary endpoint is defined by time to first occurrence.
Hospitalization analysisNights spent in hospital per year represents a utilization outcome.

10. Sources